Clinical inquiries. what are the most effective nonpharmacologic therapies for irritable bowel syndrome?
Lynch, A.; Webb, C.; Coffey, J.B.; Sams, R.
Journal of Family Practice 57(1): 57-58
2008
ISSN/ISBN: 1533-7294 PMID: 18171574 Document Number: 616792
Document emailed within 1 workday
Related Documents
Brewer, D.; Nashelsky, J.; Hansen, L.B. 2003: Clinical inquiries. what nonhormonal therapies are effective for postmenopausal vasomotor symptoms? Journal of Family Practice 52(4): 324-325; 329Shi, H.; Wan, J.; Liu, W.; Su, B. 2015: An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome Zhonghua Nei Ke Za Zhi 54(4): 326-329
Fielding, J.F. 1977: The irritable bowel syndrome. Part I: clinical spectrum Clinics in Gastroenterology 6(3): 607-622
Csef, H. 1996: Recent psychosomatic contributions to the pathogenesis and therapy of irritable colon (irritable bowel syndrome) Zeitschrift für Gastroenterologie 34(4): 250-255
Almquist, E.; Törnblom, H.; Simrén, M. 2016: Practical management of irritable bowel syndrome: a clinical review Minerva Gastroenterologica e Dietologica 62(1): 30-48
Ju, H.; Liu, X.-S.; Wang, G.-L.; Zhang, H.-Y.; Dai, S.-M.; Mao, T. 2009: The clinical characteristics of postinfectious irritable bowel syndrome in Qingdao Zhonghua Nei Ke Za Zhi 48(6): 473-475
Inoue, M. 1992: Japanese clinical statistical data of patients with irritable bowel syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 517-529
Izquierdo, S.; Rey, E.; García Alonso, M.; Almansa, C.; Díaz-Rubio, M. 2005: Has the identification of rectal hypersensitivity any implication in the clinical outcome of irritable bowel syndrome? Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 97(4): 223-228
Baldi, F.; Longanesi, A.; Blasi, A.; Monello, S.; Cestari, R.; Missale, G.; Corazziari, E.; Badiali, G.; Marzio, L.; Di Felice, F. 1992: Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study Hepato-Gastroenterology 39(5): 392-395
Wang, J.-p.; Hou, X.-h.; Ma, R.-j. 2006: The clinical features and colonic epithelium AQP8 expression in diarrhea-irritable bowel syndrome Zhonghua Nei Ke Za Zhi 45(12): 1000-1003
Remes Troche, Jé.María.; Bernal Reyes, Rúl.; Valladares Lepine, M.Antonio.; Alonso Lárraga, O.; Gómez Escudero, O.; Meléndez Mena, D. 2009: Gastroenterology diagnosis and treatment guidelines of irritable bowel syndrome; clinical features and diagnostic criteria Revista de Gastroenterologia de Mexico 74(1): 58-62
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Fliegner-Baia, M.; Keller, J.; Layer, P. 2002: How extensively should irritable bowel syndrome be investigated? Expensive bowel sounds in the abdomen MMW Fortschritte der Medizin 144(42): 28-33
García Novo, M.D.; García Burriel, J.I.; Pereda Pérez, A. 2002: Practical guides to nutrition (VII). Functional bowel disorders (equivalent to irritable bowel syndrome) Anales Espanoles de Pediatria 57(3): 253-263
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Agarwal, M.K.; Bhatia, S.J.; Desai, S.A.; Bhure, U.; Melgiri, S. 2002: Effect of red chillies on small bowel and colonic transit and rectal sensitivity in men with irritable bowel syndrome Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 21(5): 179-182
Mekkel, G.; Barta, Z.; Ress, Z.; Gyimesi, E.; Sipka, S.án.; Zeher, M. 2005: Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases Orvosi Hetilap 146(17): 797-802
Colecchia, A.; Vestito, A.; La Rocca, A.; Pasqui, F.; Nikiforaki, A.; Festi, D. 2006: Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study Minerva Gastroenterologica E Dietologica 52(4): 349-358
Russo, E.B. 2004: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters 25(1-2): 31-39
Russo, E.B. 2008: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters 29(2): 192-200